Treatment with methotrexate plus oral prednisolone versus triple therapy (methotrexate/sulfasalazine/hydroxychloroquine) plus intra-articular glucocorticoids in early rheumatoid arthritis: a prespecified nonrandomised subgroup analysis of clinical and radiographic data at 48 weeks from the NORD-STAR trial's conventional treatment arm
Annals of the Rheumatic Diseases · 2025-06 · 84 (6) · 937-948
DOI: 10.1016/j.ard.2025.03.002 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of the Rheumatic Diseases, 2025-06. Verfasst von Merete Lund Hetland und 20 weiteren Autor:innen. Beteiligte Einrichtung: DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre for Head and Orthopedics, Rigshosp…. Hauptthemen laut MEDLINE: Methotrexate, Prednisolone, Hydroxychloroquine, Arthritis, Rheumatoid. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Region Stockholm, Research Council of Finland, National Organization for Rare Disorders.
Abstract (Originalsprache)
OBJECTIVES: In the NOrdic Rheumatic Diseases Strategy Trials And Registries (NORD-STAR) trial, the active conventional arm had 2 nonrandomised regimens: arm 1A (oral group; Sweden, Norway, Netherlands, and Iceland) and arm 1B (injection group; Denmark and Finland). We report clinical, patient-reported, safety, and radiographic outcomes after 48 weeks. METHODS: Oral group received methotrexate plus oral prednisolone (20.0 mg/d, tapered rapidly, discontinued week 36); Injection group received triple therapy (methotrexate, sulphasalazine, hydroxychloroquine) and mandatory intra-articular glucocorticoid injections. The primary end point was analysed by logistic regression with several approaches for handling missing outcomes. RESULTS: In total, 137 and 80 patients were included in the oral group and injection group; 78% vs. 89% completed, respectively. At 48 weeks, adjusted clinical disease activity index remission ≤2.8 rates (95% CI) were 36% (28-44) and 55% (42-68), respectively; the risk difference (primary outcome) was 19% (2-35). Similarly, key secondary clinical, patient-reported and safety outcomes showed numerically better results in the injection group vs oral group, for example, infections occurred in 53% vs 30%, respectively. Radiographic progression (Δtotal van der Heijde-modified Sharp Score) was low: oral group: adjusted mean, 0.26 (95% CI, 0.08-0.43); injection group: adjustedd mean, 0.80 (95% CI, 0.55-1.05). Cumulative dose of oral/intra-articular glucocorticoids (median) was 1905 mg prednisolone for the oral group and 165 mg for the injection group. CONCLUSIONS: In treatment-naïve patients with early rheumatoid arthritis, triple therapy and mandatory glucocorticoid joint injections had numerically better clinical outcomes, fewer withdrawals, fewer adverse events, and lower cumulative dose of glucocorticoids, but slightly worse radiographic outcomes than treatment with methotrexate and oral prednisolone. These findings, although nonrandomised, suggest a potential for optimising treatment strategy with conventional therapies in early rheumatoid arthritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre for Head and Orthopedics, Rigshospitalet, Glostrup, Denmark; Department of Clinical Medicine, University…
- Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.
- University of Eastern Finland, Kuopio, and Hospital Nova, Wellbeing services county of Central Finland, Jyväskylä, Finland.
- Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden; Rheumatology Clinic, Sahlgrenska University Hospital, Gothenburg, Swe…
- Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
- Centre for Rheumatology, Tampere University Hospital, Tampere, Finland; Tampere University, Faculty of Social Sciences, Tampere, Finland.
Förderung
- Region Stockholm
- Research Council of Finland
- National Organization for Rare Disorders
- UCB
- Bristol-Myers Squibb Company
- Nordforsk
- Reumatikerförbundet
- UCB Inc
Zitieren
APA
Hetland, M. L., Heiberg, M. S., Sokka-Isler, T., Rudin, A., Østergaard, M., Haavardsholm, E., Rutanen, J., van Vollenhoven, R., Grondal, G., Ørnbjerg, L. M., Bøyesen, P., Lampa, J., Nurmohamed, M., Gudbjornsson, B., Uhlig, T., Kononoff, A., Lend, K., Krabbe, S., Olsen, I. C., …, & Hørslev-Petersen, K. (2025). Treatment with methotrexate plus oral prednisolone versus triple therapy (methotrexate/sulfasalazine/hydroxychloroquine) plus intra-articular glucocorticoids in early rheumatoid arthritis: a prespecified nonrandomised subgroup analysis of clinical and radiographic data at 48 weeks from the NORD-STAR trial's conventional treatment arm. Annals of the Rheumatic Diseases, 84(6), 937-948. https://doi.org/10.1016/j.ard.2025.03.002
Vancouver
Hetland ML, Heiberg MS, Sokka-Isler T, Rudin A, Østergaard M, Haavardsholm E, et al. Treatment with methotrexate plus oral prednisolone versus triple therapy (methotrexate/sulfasalazine/hydroxychloroquine) plus intra-articular glucocorticoids in early rheumatoid arthritis: a prespecified nonrandomised subgroup analysis of clinical and radiographic data at 48 weeks from the NORD-STAR trial's conventional treatment arm. Annals of the Rheumatic Diseases. 2025;84(6):937-948. doi:10.1016/j.ard.2025.03.002
BibTeX
@article{Hetland2025,
author = {Hetland, Merete Lund and Heiberg, Marte S and Sokka-Isler, Tuulikki and Rudin, Anna and Østergaard, Mikkel and Haavardsholm, Espen and Rutanen, Jarno and van Vollenhoven, Ronald and Grondal, Gerdur and Ørnbjerg, Lykke Midtbøll and Bøyesen, Pernille and Lampa, Jon and Nurmohamed, Michael and Gudbjornsson, Bjorn and Uhlig, Till and Kononoff, Aulikki and Lend, Kristina and Krabbe, Simon and Olsen, Inge C and Sexton, Joe and Hørslev-Petersen, Kim},
title = {Treatment with methotrexate plus oral prednisolone versus triple therapy (methotrexate/sulfasalazine/hydroxychloroquine) plus intra-articular glucocorticoids in early rheumatoid arthritis: a prespecified nonrandomised subgroup analysis of clinical and radiographic data at 48 weeks from the NORD-STAR trial's conventional treatment arm},
journal = {Annals of the Rheumatic Diseases},
year = {2025},
volume = {84},
number = {6},
pages = {937--948},
doi = {10.1016/j.ard.2025.03.002}
}
EUVIMED